D. E. Shaw & Co., Inc. Arvinas, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 37,124 shares of ARVN stock, worth $708,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,124

Holding current value

$708,325

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $4.43 Million - $6.13 Million	-187,227 Reduced 83.45%	37,124 $914,000
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $1.94 Million - $3.2 Million	-79,287 Reduced 26.11%	224,351 $5.97 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $7.96 Million - $11.4 Million	218,707 Added 257.51%	303,638 $12.5 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $910,018 - $2.71 Million	64,131 Added 308.32%	84,931 $3.5 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $408,512 - $586,768	20,800 New	20,800 $408,000
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $295,602 - $409,409	-7,060 Reduced 52.54%	6,377 $284,000
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $242,275 - $499,486	-6,728 Reduced 33.36%	13,437 $566,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $2.47 Million - $3.34 Million	-40,953 Reduced 67.01%	20,165 $1.36 Million
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $6.22 Million - $9.09 Million	-94,531 Reduced 60.73%	61,118 $5.02 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $3.03 Million - $4.46 Million	41,392 Added 36.23%	155,649 $12.8 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $1.39 Million - $1.94 Million	-23,065 Reduced 16.8%	114,257 $8.8 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $3.95 Million - $6.21 Million	67,964 Added 97.99%	137,322 $9.08 Million
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $119,383 - $502,191	-5,913 Reduced 7.86%	69,358 $5.89 Million
Q3 2020 Nov 16, 2020	SELL	$22.99 - $36.34 $1.93 Million - $3.06 Million	-84,112 Reduced 52.77%	75,271 $1.78 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $1.18 Million - $2.24 Million	39,473 Added 32.92%	159,383 $5.35 Million
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $329,109 - $543,528	9,973 Added 9.07%	119,910 $4.83 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $1.69 Million - $4.88 Million	109,937 New	109,937 $4.52 Million

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

Vanguard Group Inc Valley Forge, PA

7.01M
Shares

$134 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.73M
Shares

$128 Million
7.19% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$119 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.85M
Shares

$73.5 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

2.78M
Shares

$53.1 Million
1.09% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account